| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 223.70B | 222.58B | 201.79B | 198.38B | 184.81B | 173.38B |
| Gross Profit | 70.83B | 70.64B | 60.33B | 65.90B | 62.88B | 55.47B |
| EBITDA | 33.53B | 34.48B | 21.74B | 35.75B | 35.15B | 28.67B |
| Net Income | 18.23B | 17.51B | 4.11B | 14.98B | 17.18B | 12.57B |
Balance Sheet | ||||||
| Total Assets | 375.50B | 373.71B | 363.17B | 322.86B | 315.46B | 294.54B |
| Cash, Cash Equivalents and Short-Term Investments | 60.36B | 59.76B | 66.18B | 54.35B | 53.65B | 48.12B |
| Total Debt | 47.09B | 49.54B | 31.68B | 19.84B | 16.85B | 19.74B |
| Total Liabilities | 113.50B | 105.19B | 92.62B | 67.83B | 69.03B | 66.26B |
| Stockholders Equity | 261.07B | 267.53B | 269.56B | 254.02B | 245.48B | 227.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.73B | 8.21B | 7.82B | 14.45B | 11.58B |
| Operating Cash Flow | 0.00 | 25.53B | 23.24B | 20.04B | 23.14B | 24.41B |
| Investing Cash Flow | 0.00 | -27.31B | -19.41B | -15.16B | -10.64B | -17.61B |
| Financing Cash Flow | 0.00 | -4.76B | 3.82B | -7.95B | -11.09B | -8.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥857.06B | 14.76 | 19.69% | 3.15% | 10.06% | 18.03% | |
73 Outperform | ¥283.15B | 11.26 | 8.05% | 3.97% | 6.60% | 503.36% | |
69 Neutral | ¥337.36B | 10.96 | ― | 5.28% | -0.47% | 25.41% | |
66 Neutral | ¥760.52B | 10.74 | 4.79% | 4.21% | -1.21% | -27.21% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥324.97B | 36.21 | -4.00% | 3.71% | 0.24% | -234.36% | |
60 Neutral | ¥526.91B | 67.20 | 1.02% | 3.37% | -1.94% | -84.08% |